EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluating Serum Endosialin (CD248) Levels as a Diagnostic Marker in Gestational Diabetes

Tevfik Berk Bildaci, Can Ata, Ufuk Atlihan, Huseyin Aytug Avsar, Secuk Erkilinc

Journal of the ASEAN Federation of Endocrine Societies · 2025

DOI: 10.15605/jafes.040.02.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the ASEAN Federation of Endocrine Societies, 2025. Verfasst von Tevfik Berk Bildaci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Obygynecology Department, Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital, Faculty of Medicine, Izmir, Turkey. Hauptthemen laut MEDLINE: Diabetes, Gestational, Antigens, CD. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Gestational diabetes mellitus (GDM), a pregnancy-induced hyperglycemia, affects approximately 17% of pregnancies globally. Its pathophysiology remains unclear, with inflammation and vascular remodeling playing key roles. CD248, a glycoprotein linked to inflammation and vascular remodeling, has been implicated in various conditions, but its role in GDM is uncertain. Methodology. A prospective case-control study was conducted with 169 pregnant women aged 18 to 49 at a tertiary hospital. Serum CD248 levels were assessed at 24 to 28 weeks of gestation prior to the oral glucose tolerance test (OGTT). Statistical analyses evaluated the association between CD248 levels, BMI and GDM status.

Results

Of the participants, 32 (18.9%) were diagnosed with GDM. CD248 levels were lower in GDM patients (8.15 ± 10.16 ng/mL) than in controls (11.42 ± 15.44 ng/mL), but the difference was not statistically significant (p = 0.084). Although CD248 levels did not correlate with OGTT values, it was positively associated with BMI (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalAntigens, CDHumansFemalePregnancyAdultCase-Control StudiesBiomarkersProspective StudiesYoung AdultGlucose Tolerance TestAdolescentMiddle AgedBody Mass IndexApyrase

Stichwörter der Autor:innen

CD248EndosialinGestational Diabetes MellitusInflammationOGTT

Substanzen

BiomarkersAntigens, CDENTPD1 protein, humanApyrase

Autor:innen und Institutionen

  • Obygynecology Department, Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital, Faculty of Medicine, Izmir, Turkey.
  • Obgynecology Department, Private Izmir Karataş Hospital, Izmir, Turkey.
  • Obgynecology Department, Tinaztepe University Galen Hospital, Faculty of Medicine, Izmir, Turkey.

Zitieren

APA

Bildaci, T. B., Ata, C., Atlihan, U., Avsar, H. A., & Erkilinc, S. (2025). Evaluating Serum Endosialin (CD248) Levels as a Diagnostic Marker in Gestational Diabetes. Journal of the ASEAN Federation of Endocrine Societies. https://doi.org/10.15605/jafes.040.02.13

Vancouver

Bildaci TB, Ata C, Atlihan U, Avsar HA, Erkilinc S. Evaluating Serum Endosialin (CD248) Levels as a Diagnostic Marker in Gestational Diabetes. Journal of the ASEAN Federation of Endocrine Societies. 2025. doi:10.15605/jafes.040.02.13

BibTeX
@article{Bildaci2025,
  author = {Bildaci, Tevfik Berk and Ata, Can and Atlihan, Ufuk and Avsar, Huseyin Aytug and Erkilinc, Secuk},
  title = {Evaluating Serum Endosialin (CD248) Levels as a Diagnostic Marker in Gestational Diabetes},
  journal = {Journal of the ASEAN Federation of Endocrine Societies},
  year = {2025},
  doi = {10.15605/jafes.040.02.13}
}
Kostenlos starten →